WHO 2026 Global Hepatitis Report
Analysis based on 20 articles · First reported Apr 28, 2026 · Last updated Apr 29, 2026
The World Health Organization's 2026 Global Hepatitis Report highlights both progress and significant challenges in combating viral hepatitis. While there have been gains in reducing new infections and deaths, the slow and uneven progress, particularly in regions like the WHO African Region, indicates a continued burden on healthcare systems and potential economic costs associated with liver disease. The report's call for accelerated prevention, diagnosis, and treatment could spur investment in pharmaceutical companies developing vaccines and antiviral therapies, as well as healthcare infrastructure in affected nations.
The World Health Organization (WHO) released its 2026 Global Hepatitis Report, revealing measurable progress in combating viral hepatitis B and C since 2015, including a 32% drop in new hepatitis B infections and a 12% decline in hepatitis C-related deaths. However, the report warns that current rates are insufficient to meet the 2030 elimination targets, with 1.34 million lives claimed in 2024 and 1.8 million new infections annually. World Health Organization Director-General Tedros Adhanom Ghebreyesus and Dr. Tereza Kasaeva stressed the urgent need to accelerate prevention, diagnosis, and treatment efforts, citing weak health systems and inequitable access to care. The report highlights that ten countries, including Nigeria, China, India, and Indonesia, account for a significant majority of global hepatitis B and C related deaths. It also points to countries like Egypt, Georgia (country), Rwanda, and United Kingdom as examples where elimination is achievable with sustained commitment and investment, urging for stronger political commitment and increased financing.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard